Could semaglutide prevent cardiometabolic disease?

Video 4/4 in our series with Professor Alex Miras.

Professor Alex Miras takes the view that obesity is a disease. He explains why this is and how the SELECT trial should determine whether semaglutide treatment might prevent future cardiometabolic disease.

Read more here - https://medicalupdateonline.com/2023/05/could-semaglutide-prevent-cardiometabolic-disease/

Register on our website for news straight to your inbox - https://medicalupdateonline.com/register/

Watch the full series on YouTube - https://www.youtube.com/playlist?list=PLgA8niwnx0373FOaqdXBJK-4Nu4Jp7qAP
Or our website - https://medicalupdateonline.com/in-discussion-with/professor-alex-miras/

0:00 - Is obesity a disease?
2:39 - Lifelong treatment with semaglutide?
5:10 - Could semaglutide prevent future cardiometabolic problems?
7:05 - Outro

This interview was recorded on 18/04/2023.

___

Keep up to date with us across our network;

Email us at - info@medicalimi.com
Site - https://medicalupdateonline.com/
Twitter - https://twitter.com/medupdateon1ine
Instagram - https://www.instagram.com/medicalupdateonline
Facebook - https://www.facebook.com/medupdateonline
LinkedIn - https://www.linkedin.com/company/medicalupdateonline

This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2022 MedicalUpdateOnline.

IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries.

IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc.

It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond.

To find out more about IMI, please see our websites www.medicalupdateonline.com and www.medicalimi.com. Alternatively, you can email us at info@medicalimi.com.

Видео Could semaglutide prevent cardiometabolic disease? канала MedicalUpdateOnline